Results for tag: "Herpes Zoster Oticus Drug"

Herpes Zoster Oticus (HZO) is a viral infection of the ear caused by the varicella-zoster virus, the same virus that causes chickenpox. It is a rare but serious condition that can cause severe pain, hearing loss, and facial paralysis. Treatment for HZO typically involves antiviral medications, such as acyclovir, valacyclovir, and famciclovir, which can reduce the severity and duration of the infection. In some cases, corticosteroids may also be prescribed to reduce inflammation and pain. The HZO drug market is a small but growing segment of the infectious diseases drug market. It is driven by the increasing prevalence of HZO, as well as the development of new and more effective treatments. The market is expected to grow at a steady rate over the coming years, driven by the increasing demand for effective treatments. Some of the major companies in the HZO drug market include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, and Sanofi. These companies are actively developing new treatments for HZO, as well as expanding their existing product portfolios. Show Less Read more